Phase II trial

NAGOYA, Japan, June 30, 2026 Kowa Company, Ltd. has achieved a significant regulatory milestone after the U.S. Food and...

PARIS, France & SCHLIEREN/ZURICH, Switzerland, July 1, 2026 Ipsen has announced a definitive agreement to acquire Memo Therapeutics AG,...

HONG KONG, SHANGHAI & FLORHAM PARK, N.J., June 25, 2026 HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) announced that pivotal Phase II registration...

TOKYO, Japan, June 2026 Heartseed Inc. announced the successful treatment of the first patient in its Phase I/II EMERALD...

HONG KONG, June 8, 2026 Ascletis Pharma Inc. presented new clinical and preclinical data from its expanding obesity pipeline...

SCHLIEREN / ZURICH, Switzerland, June 5, 2026 Memo Therapeutics AG announced additional positive analyses from its Phase II SAFE...

SHANGHAI, China, June 8, 2026 OriCell Therapeutics has achieved a major regulatory and clinical milestone with the National Medical...

CHENGDU, China, May 29, 2026 Kelun-Biotech has presented pivotal Phase II clinical trial results for its next-generation selective RET...

TORONTO, May 22, 2026 Arch Biopartners announced that Royal Columbian Hospital (RCH) in British Columbia has dosed its first...

ALBANY, N.Y., May 19, 2026 Curia Global, Inc. has announced the completion of a major upgrade to its aseptic...